---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-019327"
form_type: "8-K"
ticker: "BACK"
cik: "0001729944"
company_name: "IMAC Holdings, Inc."
filed_at: "2023-05-26T23:59:59+00:00"
generated_at: "2026-06-14T13:10:35.370278+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# IMAC Holdings to acquire Theralink in reverse merger; Theralink shareholders to own 85%

## Summary
- Stock-for-stock reverse merger: Theralink survives as wholly owned subsidiary of IMAC (BACK).
- Theralink stakeholders expected to own ~85% of combined company; pre-merger IMAC holders ~15%.
- Merger expected to close late Q3 or early Q4 2023, subject to shareholder and regulatory approvals.
- All current IMAC directors except one to resign at close; Theralink directors appointed, Jeffrey Busch as Chairman.
- Combined company to focus on Theralink's proteomics cancer testing platform.

## SEC filing metadata
- accession: 0001493152-23-019327
- form_type: 8-K
- ticker: BACK
- cik: 0001729944
- company_name: IMAC Holdings, Inc.
- filed_at: 2023-05-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729944/000149315223019327/0001493152-23-019327-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729944/000149315223019327/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-019327
- JSON: https://secwatch.observer/filing/0001493152-23-019327.json
- Plain text: https://secwatch.observer/filing/0001493152-23-019327.txt

## Key facts
- Material Agreements
  IMAC Holdings, Inc. entered into Agreement and Plan of Merger with Theralink Technologies, Inc. (effective 2023-05-23).
  - Action: entry
  - Agreement: merger
  - Counterparty: Theralink Technologies, Inc.
  - Effective: 2023-05-23
  source text: On May 23, 2023, IMAC Holdings, Inc., a Delaware corporation (Nasdaq: BACK) (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Theralink Technologies, Inc. (OTC: THER), a Nevada corporation (“Theralink”), and IMAC Merger Sub, Inc., a Delaware corporation and a newly formed, wholly owned subsidiary of the Company (“Merger Sub”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1729944/000149315223019327/0001493152-23-019327-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.